Breast cancer is often classified as either estrogen receptor-positive (hormone-sensitive) or not. However, a new study from Karolinska Institutet suggests that this simplified classification may overlook important biological differences between patients that could affect treatment decisions. The results are published in The Lancet Regional Health – Europe.
Discover Recifes.net
This story is part of Recifes international coverage. Explore the platform and follow us — new English social channels come next.
